Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
11/06/2001 | US6312692 Method of treating graft-versus-host disease with anti-GP39 antibodies and bone marrow cells |
11/06/2001 | US6312690 Monoclonal recombinant anti-rhesus D (D7C2) antibody |
11/06/2001 | US6312689 Antibodies or antigens |
11/06/2001 | US6312688 Tyrosine-phosphatase-related protein |
11/01/2001 | WO2001081918A1 Transcriptionally regulated g protein-coupled receptor g2a |
11/01/2001 | WO2001081608A2 Viral vectors for use in monitoring hiv drug resistance |
11/01/2001 | WO2001081599A2 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors |
11/01/2001 | WO2001081590A2 Protein phosphatases |
11/01/2001 | WO2001081577A2 Dna encoding the prost 03 polypeptide |
11/01/2001 | WO2001081574A2 Regulation of nf-at interacting protein nip 45 variant |
11/01/2001 | WO2001081573A1 Edg8 receptor, its preparation and use |
11/01/2001 | WO2001081562A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof |
11/01/2001 | WO2001081551A2 Retinal pigment epithelial cell lines with extended life-span and their applications |
11/01/2001 | WO2001081544A2 Identification and uses of a hyaluronan receptor |
11/01/2001 | WO2001081540A2 Growth factor which acts through erb b-4 rtk |
11/01/2001 | WO2001081413A2 Isolated human transporter proteins, nucleic acids and uses thereof |
11/01/2001 | WO2001081412A2 Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof |
11/01/2001 | WO2001081409A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
11/01/2001 | WO2001081408A2 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
11/01/2001 | WO2001081380A2 Immunogenic pneumococcal protein and vaccine compositions thereof |
11/01/2001 | WO2001081377A2 Integrin/adhesion antagonists |
11/01/2001 | WO2001081376A2 Apo-ai/aii peptide derivatives |
11/01/2001 | WO2001081375A2 Dna & protein binding miniature proteins |
11/01/2001 | WO2001081363A1 Novel compounds |
11/01/2001 | WO2001080889A1 Product and process for regulation of t cell responses |
11/01/2001 | WO2001080883A1 Bispecific molecules and uses thereof |
11/01/2001 | WO2001080873A2 Thrombopoietin receptor modulating peptide |
11/01/2001 | WO2001080633A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
11/01/2001 | WO2001080632A1 Cell and nonhuman animal capable of amplifying hcv |
11/01/2001 | WO2001042306A3 Chimeric peptides (short b-cell epitope joined to a t-cell epitope) and their use for immunization |
11/01/2001 | WO2001036604A3 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
11/01/2001 | WO2001034640A3 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
11/01/2001 | WO2001029204A3 Protein production system |
11/01/2001 | WO2001022864A3 Sequences characteristic of bladder cancer |
11/01/2001 | WO2001009176A3 Mammalian cytokines; related reagents |
11/01/2001 | WO2000047775A9 Selection of proteins using rna-protein fusions |
11/01/2001 | WO2000040607A3 Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor |
11/01/2001 | WO2000034483A3 Compounds and methods for treatment and diagnosis of chlamydial infection |
11/01/2001 | WO2000024780A9 Compositions and methods for treating polycystic kidney disease |
11/01/2001 | US20010036647 Genetic engineering |
11/01/2001 | US20010036456 Administering Protein C |
11/01/2001 | EP1144642A3 Compounds and methods for treatment and diagnosis of chlamydial infection |
11/01/2001 | CA2410024A1 Identification and uses of a hyaluronan receptor |
11/01/2001 | CA2407455A1 Immunogenic pneumococcal protein and vaccine compositions thereof |
11/01/2001 | CA2407449A1 Novel compounds |
11/01/2001 | CA2407424A1 Retinal pigment epithelial cell lines with extended life-span and their applications |
11/01/2001 | CA2407377A1 Dna & protein binding miniature proteins |
11/01/2001 | CA2407167A1 Thrombopoietin receptor modulating peptide |
11/01/2001 | CA2407086A1 Integrin/adhesion antagonists |
11/01/2001 | CA2407084A1 Isolated human transporter proteins, nucleic acids and uses thereof |
11/01/2001 | CA2407083A1 Apo-ai/aii peptide derivatives |
11/01/2001 | CA2407081A1 Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof |
11/01/2001 | CA2407077A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
11/01/2001 | CA2406855A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof |
11/01/2001 | CA2406839A1 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
11/01/2001 | CA2406725A1 Edg8 receptor, its preparation and use |
11/01/2001 | CA2406264A1 Protein phosphatases |
11/01/2001 | CA2405961A1 Bispecific molecules and uses thereof |
11/01/2001 | CA2405138A1 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors |
11/01/2001 | CA2403916A1 Viral vectors for use in monitoring hiv drug resistance |
10/31/2001 | EP1149913A1 Cytokine immunoconjugates |
10/31/2001 | EP1149912A2 Polyhydroxyalkanoate synthase and gene encoding the same |
10/31/2001 | EP1149909A1 Methods for regulating protein conformation using molecular chaperones |
10/31/2001 | EP1149908A1 TGF-beta type receptor cDNAs and uses thereof |
10/31/2001 | EP1149906A1 Thrombopoietin receptor modulating peptide |
10/31/2001 | EP1149905A1 Methods and compositions for polypeptide engineering |
10/31/2001 | EP1149904A1 Methods and compositions for polypeptide engineering |
10/31/2001 | EP1149168A2 Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins |
10/31/2001 | EP1149167A2 Viral vaccine |
10/31/2001 | EP1149166A2 GENES IDENTIFIED AS REQUIRED FOR PROLIFERATION IN $i(ESCHERICHIA COLI) |
10/31/2001 | EP1149165A1 Basb055 polynucleotide and polypeptide from neisseria meningitidis. uses thereof |
10/31/2001 | EP1149164A2 Neisseria meningitidis polypeptides |
10/31/2001 | EP1149163A2 Human serum albumin |
10/31/2001 | EP1149115A1 METHODS OF ELICITING BROADLY NEUTRALIZING ANTIBODIES TARGETING HIV-1 gp41 |
10/31/2001 | EP1149114A2 Polypeptides involved in immune response |
10/31/2001 | EP1149111A1 Method and composition for angiogenesis inhibition |
10/31/2001 | EP1148782A2 Plant resistance to insect pests mediated by viral proteins |
10/31/2001 | EP1148779A2 Expression of secreted human alpha-fetoprotein in transgenic animals |
10/31/2001 | EP0842279B1 Helper viruses for preparing recombinant viral vectors |
10/31/2001 | EP0815141B1 Antibodies active against a fusion polypeptide comprising a histidine portion |
10/31/2001 | EP0803065B1 A-protein as a diagnostic of cancer |
10/31/2001 | EP0779896B1 New process for the production of biologically active protein (tgf) |
10/31/2001 | EP0699077B1 Hiv immunogenic complexes |
10/31/2001 | EP0693085B1 Method of coupling ligands within porous supports (p.e. azlactone) and uses thereof |
10/31/2001 | EP0519001B1 PURIFIED gp120 COMPOSITION RETAINING NATURAL CONFORMATION |
10/31/2001 | EP0444181B1 C-erbb-2 external domain: gp75 |
10/31/2001 | EP0201540B2 Envelope antigens of lymphadenopathy associated virus and their applications |
10/31/2001 | CN1320167A An i(in vitro) activity assay for human hepatitis B virus (HBV) DNA polymerase, and its use for screening for inhibitors of HBV DNA polymerase |
10/31/2001 | CN1320164A Novel collectin |
10/31/2001 | CN1320043A Mutant cholera holotoxin as an adjuvant |
10/31/2001 | CN1319673A Health food prepared from yeast extract |
10/31/2001 | CN1319666A Human testis development relative gene coding protein |
10/31/2001 | CN1319665A Human testics kinesin 9 gene coding protein |
10/30/2001 | US6310197 Nucleotide sequences for use in treatment of alzheimer's disease |
10/30/2001 | US6310184 Immunoglobulin for the treatment and prevention of mammary and prostate gland cancers |
10/30/2001 | US6309892 Detecting immunoglobulins in sample; incubate sample with dense microspheres, monitor and measure immune reponse |
10/30/2001 | US6309881 Aldehyde and ketone reactants are contacted with antibody molecules or molecules containing antibody combining site portions that catalyze an aldol addition reaction |
10/30/2001 | US6309880 Antibodies specific for CD4-binding domain of HIV-1 |
10/30/2001 | US6309877 Polynucleotides encoding motoneuronotrophic factors |
10/30/2001 | US6309868 Cloning of the prolyl-dipeptidyl-peptidase from Aspergillus oryzae |